KGP-25
KGP-25 is an inhibitor of voltage-gated sodium channel 1.8 (Nav1.8), which can be used for analgesia by targeting Nav1.8 in the peripheral nervous system (PNS) . KGP-25 can also target γ-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for general anesthesia[1].
Product Specifications
UNSPSC
12352005
Target
GABA Receptor; Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/kgp-25.html
Purity
95.0
Smiles
CC(C1=C(C(C(C)C)=CC=C1)OC(OCC[NH+](CC)CC)=O)C.[Cl-]
Molecular Formula
C19H32ClNO3
Molecular Weight
357.92
References & Citations
[1]Huang T, ey al. Molecular Transformers: Adaptive Multitarget Ligands for Esterase-Induced Transition from Analgesics to Anesthetics. J Med Chem. 2024 Jul 25;67 (14) :12349-12365.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
219840 5 µg
HER2, Active, Recombinant, Human (ERBB2, Receptor tyrosine-protein kinase erbB-2, Tyrosine Kinase-type Cell Surface Receptor Her2, neu Oncoprotein, CD340, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, Metastatic lymph node gene 19 protein, p185erbB2) discontinued
Ask
View Details 
GTR15320957 1 Vial
Lentiviral human LRRC58 shRNA (UAS) - Lentiviral human LRRC58 shRNA (UAS, iRFP) (25)
Ask
View Details 